A comprehensive statistical analysis of COVID-19 trends: Global and United States insights through ARIMA, regression, and spatial models
Lei Zhihao
Microbes & Immunity ›› 2025, Vol. 2 ›› Issue (3) : 108 -129.
A comprehensive statistical analysis of COVID-19 trends: Global and United States insights through ARIMA, regression, and spatial models
The COVID-19 pandemic has driven the need for accurate data analysis and forecasting to support public health decision-making. This study applied autoregressive integrated moving average (ARIMA) models and ARIMA models with exogenous variables to predict short-term trends in confirmed COVID-19 cases across several regions, including the United States of America, Asia, Europe, and Africa. Model performance was compared between ARIMA and the automated model selection function, auto.arima, and anomaly detection was performed to investigate discrepancies between predicted and observed case numbers. Additionally, the study explored the relationship between vaccination rates and new case trends while also examining the influence of socioeconomic factors—such as gross domestic product per capita, human development index, and healthcare resources availability—on COVID-19 incidence across countries. The findings provide valuable insights into the effectiveness of predictive models and highlight the significant role of socioeconomic factors in the spread of the virus, thereby contributing to the development of more effective strategies for future epidemic prevention and control.
Autoregressive integrated moving average model / COVID-19 / Public health / Socioeconomic factors / Time series forecasting / Vaccination rates
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern [Last accessed on 2021 Nov 26].. |
| [40] |
World Health Organization. Tracking SARS-CoV-2 Variants; 2022. Available from: https://www.who.int/en/activities/tracking-sars-cov-2-variants [Last accessed on 2025 Jun 16]. |
| [41] |
World Health Organization. Update on Omicron Subvariants and the Global COVID-19 Situation; 2022. Available from: https://www.who.int/news-room/feature-stories/detail/ update-on-omicron-subvariants-and-the-global-covid-19- situation [Last accessed on 2024 Sep 24]. |
| [42] |
World Health Organization. Weekly Epidemiological Update on COVID-19; 2023. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19 [Last accessed on 2023 Jan 11].; |
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
/
| 〈 |
|
〉 |